JamesDPeytonMD

PubMed

• 38 citations
  A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
  Andrew H. Ko, Patrick B. Murphy, James D. Peyton, Dianna Shipley, Ahmed Al-Hazzouri, Francisco Antonio Rodriguez, Mark Sanders Womack, Henry Q. Xiong, David M. Waterho...> ;The Oncologist. 2017 Dec 1
• 12 citations
  A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases ...
  Johanna C. Bendell, Ahmed Zakari, James D. Peyton, Ralph V. Boccia, Mark Moskowitz, Victor G. Gian, Andrew Lipman, David M. Waterhouse, Richard LoCicero, Chris Earwood...> ;The Oncologist. 2016 Mar 1
• 42 citations
  A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer.
  Johanna C. Bendell, A. A. Meluch, James D. Peyton, Mark A. Rubin, David M. Waterhouse, Charles D. Webb, Howard A. Burris, John D. Hainsworth> ;Clinical Advances in Hematology & Oncology. 2012 Jul 1
• 24 citations
  A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced n...
  David R. Spigel, John D. Hainsworth, Dianna Shipley, Thomas J. Ervin, Peter C. Kohler, Eric T. Lubiner, James D. Peyton, David M. Waterhouse, Howard A. Burris, F. Anth...> ;Journal of Thoracic Oncology. 2012 Jan 1
• 47 citations
  Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck:...
  John D. Hainsworth, David R. Spigel, F. Anthony Greco, Dianna Shipley, James D. Peyton, Mark A. Rubin, Michael A. Stipanov, A. A. Meluch> ;Cancer Journal. 2011 Sep 1
• 4 citations
  A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer.
  Denise A. Yardley, Davey B. Daniel, Michael A. Stipanov, D. Randolph Drosick, Mark Mainwaring, James D. Peyton, Mythili Shastry, John D. Hainsworth> ;Cancer Investigation. 2010 Sep 14
• 61 citations
  Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
  John D. Hainsworth, Jeffrey R. Infante, David R. Spigel, James D. Peyton, Dana S. Thompson, Cassie M. Lane, Bobby L. Clark, Mark S. Rubin, D. Trent, Howard A. Burris> ;Cancer. 2010 Sep 1
• 2 citations
  A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancer
  David R. Spigel, John D. Hainsworth, Jitendra G. Gandhi, Victor G. Gian, James D. Peyton, Kimberly West-Osterfield, Bobby L. Clark, Elizabeth R. Vazquez, Suzanne F. Jo...> ;Journal of Thoracic Oncology. 2010 Jun 1
• Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carci...
  Meluch AA, Spigel D, Burris HA, Lane C, Peyton JD, Shipley D, Rubin M, Stipanov M, Greco FA, Hainsworth JD> ;J. Clin. Oncol.. 2009-05-20
• Phase II trial of bevacizumab and everolimus in the treatment of patients with metastatic melanoma: Preliminary results.
  Peyton JD, Spigel DR, Burris HA, Lane C, Rubin M, Browning M, Trent D, Hainsworth JD> ;J. Clin. Oncol.. 2009-05-20
• Maintenance gefitinib (G) after chemoradiotherapy (CRT) in patients (pts) with unresectable stage IIIA/B non-small cell lung cancer (NSCLC): A phase II trial of the Mi...
  Gray JR, Spigel DR, Hainsworth JD, Vazquez E, Peyton JD, Raefsky EL, Malik R, Marsland T, Waples J, Greco FA> ;J. Clin. Oncol.. 2006-06-20
• Join now to see all